David Emerson Jorden, Director at CYTOMEDIX INC (CMXI), bought 22,500 shares at $0.39 ($9K) on 2011-05-19, disclosed to the SEC on 2011-05-20.
Open-market purchase of $9k CMXI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| AURX | BUY | 2017-08-14 | $54K | — | Filing → |
| PLXP | BUY | 2017-06-16 | $450K | — | Filing → |
| PrivateNuo Therapeutics, Inc. | BUY | 2016-07-29 | $138K | — | Filing → |